Skip to content

A retrospective study based on medical records for tripathin and bisphosphonates in the treatment of postmenopausal osteoporosis

A retrospective study based on medical records for tripathin and bisphosphonates in the treatment of postmenopausal osteoporosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032675
Enrollment
Unknown
Registered
2020-05-06
Start date
2020-05-08
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

Group A:Subcutaneous injection of PTH
Group B:Intravenous bisphosphonates

Sponsors

Army Medical Center of PLA
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Aged >= 50 years, and the female should reach menopause for at least 1 year; 2. In line with the diagnostic criteria of severe osteoporosis, the results of DXA bone mineral density examination suggested that the t-value of one of the effective sites (lumbar 1-4, femur neck, total hip) was less than -1.0; 3. With at least one or more vertebral compression fractures (low-trauma fractures).

Exclusion criteria

Exclusion criteria: 1. Patients with osteomalacia; 2. Renal insufficiency was found at baseline, eGFR <= 35ml/min/1.73m2; 3. Hyperthyroidism, hyperparathyroidism, adrenocortical hypofunction, hypophysis; 4. Patients with hypercalcemia at baseline; 5. Patients diagnosed with bone tumor or tumor bone metastasis.

Design outcomes

Primary

MeasureTime frame
Bone mineral density;Bone metabolism;liver function;renal function;Blood biochemistry;VAS;ODI;

Countries

China

Contacts

Public ContactLiu Peng
liupengd@163.com+86 18983661991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026